Shijia Yu

445 total citations
15 papers, 345 citations indexed

About

Shijia Yu is a scholar working on Cancer Research, Molecular Biology and Epidemiology. According to data from OpenAlex, Shijia Yu has authored 15 papers receiving a total of 345 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Cancer Research, 5 papers in Molecular Biology and 4 papers in Epidemiology. Recurrent topics in Shijia Yu's work include Cancer-related molecular mechanisms research (6 papers), MicroRNA in disease regulation (3 papers) and Neurological Disease Mechanisms and Treatments (2 papers). Shijia Yu is often cited by papers focused on Cancer-related molecular mechanisms research (6 papers), MicroRNA in disease regulation (3 papers) and Neurological Disease Mechanisms and Treatments (2 papers). Shijia Yu collaborates with scholars based in China. Shijia Yu's co-authors include Juan Feng, Mingjun Yu, Zhongqi Bu, Xin He, Lulu Wen, Tao Bai, Pingping He, Yun Qiao, Xue Cai and Yongsheng Chen and has published in prestigious journals such as Frontiers in Pharmacology, Aging Cell and Journal of Cellular and Molecular Medicine.

In The Last Decade

Shijia Yu

14 papers receiving 339 citations

Peers

Shijia Yu
Si Guo China
Yun-Hee Bae South Korea
Huayan Wu China
Ashhar Ali United States
Xue Peng China
Cui Zhou China
Shijia Yu
Citations per year, relative to Shijia Yu Shijia Yu (= 1×) peers Dongyao Hou

Countries citing papers authored by Shijia Yu

Since Specialization
Citations

This map shows the geographic impact of Shijia Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shijia Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shijia Yu more than expected).

Fields of papers citing papers by Shijia Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shijia Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shijia Yu. The network helps show where Shijia Yu may publish in the future.

Co-authorship network of co-authors of Shijia Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Shijia Yu. A scholar is included among the top collaborators of Shijia Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shijia Yu. Shijia Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Huang, Qiuping, Shijia Yu, Zhongyi Guo, et al.. (2022). A synthetic toll-like receptor 7 agonist inhibits porcine reproductive and respiratory syndrome virus replication in piglets. Veterinary Microbiology. 271. 109475–109475. 7 indexed citations
2.
Bai, Tao, Shijia Yu, & Juan Feng. (2022). Advances in the Role of Endothelial Cells in Cerebral Small Vessel Disease. Frontiers in Neurology. 13. 861714–861714. 45 indexed citations
3.
Yu, Shijia, et al.. (2022). LncRNA KCNQ1OT1 predicts further cerebral events in patients with transient ischemic attack. Frontiers in Pharmacology. 13. 961190–961190. 2 indexed citations
4.
Yu, Mingjun, et al.. (2021). HOXC6/8/10/13 predict poor prognosis and associate with immune infiltrations in glioblastoma. International Immunopharmacology. 101(Pt A). 108293–108293. 10 indexed citations
5.
Yu, Shijia & Mingjun Yu. (2020). Severe Acute Respiratory Syndrome Coronavirus 2-Induced Neurological Complications. Frontiers in Cell and Developmental Biology. 8. 605972–605972. 10 indexed citations
6.
Yu, Shijia, Mingjun Yu, Zhongqi Bu, Pingping He, & Juan Feng. (2020). FKBP5 Exacerbates Impairments in Cerebral Ischemic Stroke by Inducing Autophagy via the AKT/FOXO3 Pathway. Frontiers in Cellular Neuroscience. 14. 193–193. 34 indexed citations
7.
Yu, Mingjun, et al.. (2020). Linc00475 promotes the progression of glioma by regulating the miR‐141‐3p/YAP1 axis. Journal of Cellular and Molecular Medicine. 25(1). 463–472. 15 indexed citations
8.
Yu, Shijia, et al.. (2020). Stat6 Correlates with Response to Immune Checkpoint Blockade Therapy and Predicts Worse Survival in Thyroid Cancer. Biomarkers in Medicine. 14(11). 955–967. 6 indexed citations
9.
Yu, Mingjun, et al.. (2019). Knockdown of linc01023 restrains glioma proliferation, migration and invasion by regulating IGF-1R/AKT pathway. Journal of Cancer. 10(13). 2961–2968. 15 indexed citations
10.
Yu, Shijia, Mingjun Yu, Xin He, et al.. (2019). KCNQ1OT1 promotes autophagy by regulating miR‐200a/FOXO3/ATG7 pathway in cerebral ischemic stroke. Aging Cell. 18(3). e12940–e12940. 109 indexed citations
11.
Yu, Mingjun, et al.. (2018). Over-Expressed FEZF1 Predicts a Poor Prognosis in Glioma and Promotes Glioma Cell Malignant Biological Properties by Regulating Akt-ERK Pathway. Journal of Molecular Neuroscience. 65(4). 411–419. 12 indexed citations
12.
Tang, Weifeng, Yan Wang, Sheng Chen, et al.. (2015). Investigation of Cytotoxic T‐lymphocyte antigen 4 Polymorphisms in Gastric Cardia Adenocarcinoma. Scandinavian Journal of Immunology. 83(3). 212–218. 30 indexed citations
13.
Cai, Xue, Weiguo Huang, Yun Qiao, et al.. (2013). Inhibitory effects of curcumin on gastric cancer cells: A proteomic study of molecular targets. Phytomedicine. 20(6). 495–505. 47 indexed citations
14.
Yu, Shijia. (2012). Effects of Mudan particles on serum 5-HT and β-EP expressions in diabetic rats. 1 indexed citations
15.
Yu, Shijia, et al.. (2009). Effects of Rhein on resistin mRNA expression of adipose tissue and plasma free fatty acid in diabetic obese rats. Zhonghua zhongyiyao zazhi. 24(8). 1061–1063. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026